However, an elevated C-reactive protein concentration (>10 mg l−1) was seen in only 12% of patients, a proportion lower than previously seen in both primary operable disease (approximately 20–40%) and in advanced cancer (approximately 40–80%). This evidence concerns the gene CRP and cancer.